Benzodiazepine

ApprovedSmall molecule

Johnson & Johnson

Benzodiazepine is one of 64 small molecule programs targeting Agitation. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

DeliriumActive, not recruiting

SchizophreniaActive, not recruiting

DeliriumApproved

Active, not recruiting

SchizophreniaPreclinical

Active, not recruiting

Competition

Competitive Landscape

583 competitors in Schizophrenia

#DrugCompanyPhaseTrials

Benzodiazepine

Johnson & Johnson

Approved

1 2

Celexa

AbbVie

Preclinical

4 3

Ozempic

Novo Nordisk

Preclinical

1 4

Resotran

Takeda

Preclinical

1 5

Inapsine

Alnylam Pharmaceuticals

Preclinical

1 6

Zocor

OOrganon and Co

Preclinical

6 7

Depakote

Ibrance

Lunesta

3 10

Catapres

Boehringer Ingelheim

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Delirium1 trial

Decreasing the Incidence of Delirium After Cardiac Surgery

Withdrawn·UUniversity of California, Los Angeles·Phase 4·NCT02119806

Agitation1 trial

IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation

Completed· Johnson & Johnson logo

Johnson & Johnson·Phase 4·NCT01050478·56 enrolled

Pregnancy1 trial

Maternal and Neonatal Outcomes Following Exposure to Benzodiazepines During Pregnancy

Completed·SSungkyunkwan University··NCT04856436·3,094,227 enrolled

Benzodiazepines1 trial

Benzodiazepines in Opiate Replacement Therapy

Completed·—··NCT04622995·46,899 enrolled

Schizophrenia1 trial

Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia

Completed·NNew York State Psychiatric Institute··NCT02775864·81,921 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Benzodiazepine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Benzodiazepine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Benzodiazepine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Johnson & Johnson company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: Johnson & Johnson

Benzodiazepine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Delirium1 trial

Agitation1 trial

Pregnancy1 trial

Benzodiazepines1 trial

Schizophrenia1 trial

References

Drug Info

Quick Facts

Related News